[Analysis of PKD2 gene variant and protein localization in a pedigree affected with polycystic kidney disease]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021 Jan 10;38(1):47-51. doi: 10.3760/cma.j.cn511374-20191204-00619.
[Article in Chinese]

Abstract

Objective: To detect the mutation site in a pedigree affected with autosomal dominant polycystic kidney disease (ADPKD) and verify its impact on the protein function.

Methods: Peripheral blood samples were collected from the proband and his pedigree members for the extraction of genomic DNA. Mutational analysis was performed on the proband through whole-exome sequencing. Suspected variant was verified by Sanger sequencing. A series of molecular methods including PCR amplification, restriction enzyme digestion, ligation and transformation were also used to construct wild-type and mutant eukaryotic expression vectors of the PKD2 gene, which were transfected into HEK293T and HeLa cells for the observation of protein expression and cell localization.

Results: The proband was found to harbor a c.2051dupA (p. Tyr684Ter) frame shift mutation of the PKD2 gene, which caused repeat of the 2051st nucleotide of its cDNA sequence and a truncated protein. Immunofluorescence experiment showed that the localization of the mutant protein within the cell was altered compared with the wild-type, which may be due to deletion of the C-terminus of the PKD2 gene.

Conclusion: The c.2051dupA (p. Tyr684Ter) mutation of the PKD2 gene probably underlay the pathogenesis of ADPKD in this pedigree.

Publication types

  • Case Reports

MeSH terms

  • DNA Mutational Analysis
  • Exome Sequencing
  • Female
  • Frameshift Mutation*
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Male
  • Pedigree
  • Polycystic Kidney, Autosomal Dominant* / genetics
  • Polycystic Kidney, Autosomal Dominant* / physiopathology
  • Protein Kinase D2
  • Protein Kinases* / genetics
  • Protein Transport / genetics

Substances

  • Protein Kinase D2
  • Protein Kinases